Inhibition of 2-deoxy-D-glucose transport by theophylline, caffeine and papaverine in alveolar macrophages.
D000818:Animals; D001692:Biological Transport / Q000187:drug effects*; D003994:Bucladesine / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005947:Glucose / Q000037:antagonists & inhibitors* / Q000378:metabolism; D066298:In Vitro Techniques; D007700:Kinetics; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D010208:Papaverine / Q000494:pharmacology*; D011453:Prostaglandins / Q000494:pharmacology; D011650:Pulmonary Alveoli / Q000166:cytology*; D013395:Sucrose / Q000378:metabolism; D013806:Theophylline / Q000494:pharmacology*; D014316:Tritium
D002250:Carbon Radioisotopes; D011453:Prostaglandins; D014316:Tritium; D002110:Caffeine; D013395:Sucrose; D003994:Bucladesine; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D006152:Cyclic GMP; D005947:Glucose